SUSTAINEDALLROUNDLEADERSHIP

ContinuedOutstandingClinicalPerformance EnhancedPatientExperience
FY12ConsolidatedRevenuesup20.8%atRs.31,475million ConsolidatedEBITDAup22.5%atRs.5,131million ConsolidatedPATup19.3%atRs.2,194million BoardrecommendsadividendofRs.4pershare Chennai,May29,2012:ApolloHospitalsEnterpriseLtd(AHEL),(BSE:508869,NSE:INE437A01024), theHealthcarePioneerandleadingproviderofqualityclinicalcarereporteditsconsolidated financialresultsaccordingtoIndianGAAPforthequarterandfinancialyearendedMarch31,2012. TheresultsreinforceApollosleadershipasthemostvaluableandtrustedhealthcareprovider. ThecompanycrossedtheRs.30BillionmilestonepostingconsolidatedannualrevenuesofRs.31.5 Billionwithagrowthof20.8%YonY.ConsolidatedEBITDAwasup22.5%atRs.5,131Millionwith PATgrowingat19.3%atRs.2,194Million.BoardrecommendsDividendofRs4perShare Commentingonthe201112performance,Dr.PrathapCReddy,Chairmansaid,ApolloHospitals continuestodemonstratestrongmomentumandsustainedleadershipthroughthefourthquarter to close out a year of strong growth and profitability. He added, With our mission to give our customersthelatestintreatmenttechnologies,wehavedeliveredclinicalexcellenceonparwith theworldsbestbenchmarks.ThevalueofcareisfurtherenhancedbyouracclaimedpatientCare emphasis that has helped us to put in place the worlds busiest transplantation program and undertake effective initiatives such as Robotic Surgery, a minimally invasive surgery. The re accreditation of our facilities at Chennai, Delhi, Bangalore and Dhaka by JCI and the NABH accreditation awarded to our hospitals in Ahmedabad, Noida and Secunderabad further underscore our rigor on standards. The team has once again delivered a robust growth, while improvingprofitability,whichistrulyareflectionofourbusinessmodel. The year ahead per Dr. Prathap C Reddy is one of further impetus to our key pillars of Patient CareExcellence,ClinicalExcellence,ValueExcellence,andthoughtthroughexpansionstobringthe best of technical and clinical advances for the benefit of customers. We have also initiated significant transformation initiatives that would further set us of up to achieve balanced growth across all our Centers of Excellence, Geographies and Formats. Our emphasis on using Information Technology to transform Health Care is yielding results in process efficiency and enhancedconnectivitywithDoctors&patients.

FinancialHighlights

AuditedStandaloneFY12Performance(incomparisontoFY11) Revenuesgrew20.1%toRs.28,001millioncomparedtoRs.23,320millioninFY11. EBITDAgrew23.0%toRs.4,644millionasagainstRs.3,775millioninFY11.TheEBITDA marginimprovedby40basispointsto16.6%. PATwasRs.2,310millionvs.Rs.1,817millioninFY11,growthof27.1%. DilutedEPSofRs.16.86pershareinFY12 TheBoardsofDirectorshasrecommendedadividendofRs.4pershare. AuditedConsolidatedFY12Performance Revenuesgrew20.8%toRs.31,475millioncomparedtoRs.26,054millioninFY11. EBITDAgrew22.5%toRs.5,131millionasagainstRs.4,190millioninFY11.TheEBITDA marginimprovedby22basispointsto16.3%. PATwasRs.2,194millionvs.Rs.1,839millioninFY11,agrowthof19.3%. DilutedEPSofRs.16.01pershareinFY12 AuditedStandaloneQ4FY12Performance(incomparisontoQ4FY11) Revenuesgrew19.8%toRs.7,446millioncomparedtoRs.6,214millioninQ4FY11. EBITDAgrew25.8%toRs.1200millionasagainstRs.954millioninQ4FY11. PATwasRs.593millionvs.Rs.471millioninQ4FY11,growthof26.0%. DilutedEPSofRs.4.27pershareinQ4FY12 AuditedConsolidatedQ4FY12Performance Revenuesgrew20.4%toRs.8,572millioncomparedtoRs.7,121millioninQ4FY11. EBITDAgrew25.9%toRs.1,309millionasagainstRs.1,039millioninQ4FY11. PATwasRs.515millionvs.Rs.466millioninQ4FY11,growthof10.4%. DilutedEPSofRs.3.70pershareinQ4FY12

 ClinicalHighlights
ApolloTransplantInstitutes:(ATI) We completed 929 Solid organ transplants in a single calendar Year to be the first to reach this milestoneandbecomethebusiestprogramofitskindintheworld. NewtransplantfacilitiesstartedinBhubaneshwarandLudhianawhileconsolidatingitsprogramsin BangaloreandHyderabad. ApolloInstituteofRoboticSurgery: This was launched in Chennai in November 2011 and has successfully completed 55 complicated surgerieswithroboticassistance. ExpandingthisreachinCardiac,HeadandNeckSurgeries. RadiationTherapy: PlanstointroduceTrueBeamStx,duringthefirstquarterofFY13inBangalore.Consideredasoneofthe worlds most advanced radiation therapy machine, the TrueBeam Stx is an advanced radiation therapy machine engineered to perform the most sophisticated radiation therapy and radiosurgery procedures with pinpoint accuracy and ultrafine precision. It will enable faster, accurate tumor targeting in the treatmentofchallengingcancersthroughoutthebody,includingthoseinthebrain,pancreasandliver. CardiacExcellence: TheCardiacCoEhasthusfarcompletedover120,000surgeries,aglobalmilestone. ClinicalBenchmarks: FurtherenhancementoffocusonourrespectedGlobalClinicalExcellenceBenchmarkprogram(ACE @25) that measures clinical outcome across 25 additional outcomes aligned to our Centers of Excellence.Thisaugmentedprogramisbeingrunacrossourcenters.

Attached:Detailstotheannouncement
Forfurtherinformation,pleasecontact:

RKrishnakumar ApolloHospitalsEnterpriseLtd. Krishnakumar_r@apollohospitals.com +914428297840

MayankVaswani CitigateDeweRogerson mayank@cdrindia.com +912266451230

AboutApolloHospitalsEnterpriseLtd.(AHEL)
Itwasin1983,thatDr.PrathapReddymadeapioneeringendeavourbylaunchingIndiasfirstcorporate hospitalApolloHospitalinChennai.Now,asAsialargestandmosttrustedhealthcaregroup,itspresence includesover8,200bedsacross50Hospitals,1,364Pharmacies,100primarycareanddiagnosticClinics, 100 Telemedicine units across 9 countries, medical business process outsourcing services, Health Insurance services, Global Projects Consultancy, 15 colleges of Nursing and Hospital Management and a ResearchFoundationwithafocusonglobalClinicalTrials,epidemiologicalstudies,stemcellandgenetic research. Disclaimer Some of the statements in this document that are not historical facts are forward looking statements. These forwardlooking statements include our financial and growth projections as well as statements concerningourplans,strategies,intentionsandbeliefsconcerningourbusinessandthemarketsinwhich weoperate. These statements are based on information currently available to us, and we assume no obligation to update these statements as circumstances change. There are risks and uncertainties that could cause actualeventstodiffermateriallyfromtheseforwardlookingstatements.Theserisksinclude,butarenot limited to, the level of market demand for our services, the highlycompetitive market for the types of servicesthatweoffer,marketconditionsthatcouldcauseourcustomerstoreducetheirspendingforour services,ourabilitytocreate,acquireandbuildnewbusinessesandtogrowourexistingbusinesses,our abilitytoattractandretainqualifiedpersonnel,currencyfluctuationsandmarketconditionsinIndiaand elsewherearoundtheworld,andotherrisksnotspecificallymentionedhereinbutthosethatarecommon toindustry. Further,thisdocumentmaymakereferencestoreportsandpublicationsavailableinthepublicdomain. Apollo Hospitals Enterprise Ltd. makes no representation as to their accuracy or that the company subscribestothoseviews/findings. The Company on a quarterly basis adopts and publishes Standalone financial results as per the stock exchangelistingagreementrequirements.TheconsolidatedfinancialresultsprovidedfortheQuarterare unauditedandforinformationpurposesonly.

Detailstotheannouncement
KeyAchievements4Pillars
At Apollo,corporatesuccessisanchored by 4 key pillarsClinicalExcellence, Technological Excellence, PatientCareExcellenceandValueExcellence.ApolloHospitalsbelievesindeliveryofbestpatientcare, employingbestinclassproceduresandtechnologieswithaneyeonsustainablegrowthperformance. ClinicalExcellence:Apollostrivestomaintainconsistentlyhigherratesofcasesuccessrates. Technological Excellence: Apollo relies on worldclass, stateoftheart equipment, devices and procedurestoconsistentlydeliversuperiorclinicaloutcomes. PatientCareExcellence:Apolloisdrivenbypatientwellbeing. Value Excellence: Apollo balances performance goals with topnotch healthcare service delivery whichisaffordabletothemasses.

OperatingHighlights
TheJoinHandsPatientSafetyCampaignwaslaunchedbyDrPrathapCReddy,MsKiranMazumdar

Shaw (Chairperson & MD Biocon) and Sir Muer Gray (Chief Knowledge Officer NHS, UK). The campaignisonethatcallsorganizationstocomeonasingleplatform,worktogetherandsharebest practices with each other. It covers 1,88,007 Hospitals working towards one common mission PatientSafety.

TheFirstEditionoftheInternationalCongressonPatientSafety,BestPracticesforAsiawasheldin Hyderabadduring2122April,2011. The Department of Neurosurgery, Institute of Neurosciences, Apollo Hospitals at Bhubaneswar carriedouttwolevelcervicaldiscreplacementsbyprostheticCervicaldiscforthefirsttimeinthe stateofOdishaandeasternpartofIndia.Thepatient,aged54years,hadanexcellentNeurological recoveryandwasdischargedin3days. DuringFY12,ApolloHospitalsatDhaka,Bangalore,DelhiandChennaiwerereaccreditedbytheJCI whileApolloHospitalsatAhmedabad,NoidaandSecunderabadreceivedNABHCertification. Apollo Hospitals ,Kolkata successfully treated a patient suffering from a liver tumour with a new radiotherapytechniquecalledStereotacticBodyRadiationTherapy(SBRT).Withthistechniquehigh dose radiation was delivered precisely to the target in three fractions (one fraction on alternate days)andtheradiationtreatmentwascompletedwithinfivedays.

SegmentwisePerformanceUpdate
Hospitals Revenues of the hospital division of Apollo Hospitals Enterprise Limited (Standalone) (consisting of hospitalservices,hospitalbasedpharmaciesandconsulting)increasedby16.1%toRs.19,402millionin FY12comparedtoRs.16,712millioninFY11. ChennaiclusterdisplayedahealthyrevenuegrowthinQ4FY12. Hyderabad cluster continues to display strong growth. Average occupancy at 577 beds (62% utilizationon930beds)ascomparedto526beds(65%utilizationon809beds)inFY12.Strong volume growth on focus COEs like Cardiology (36%), Neurosciences (23%), Gastro (27%), Transplants(64%)andOncology(30%). Bhubaneswar occupancy at 144 beds (65% utilization on an increased capacity of 220 beds) as comparedto78bedsinFY12,duetoincreasedpatientfootfallsandadmissions.Q4FY12EBITDA marginsat16%from5%inthesameperiodlastyear. StandalonePharmacies ApolloPharmaciesreportedsustainedgrowthinrevenuesatRs.2,377millioninQ4FY12,growing30.5% from Rs. 1,821 million in Q4FY11. The SAP business also demonstrated continued operational improvement with expansion in EBITDA of 115 bps from Rs. 24 million in Q4FY11 to Rs. 59 million in Q4FY12.ThebusinessreportedimprovedprofitabilitywithanEBITofRs.36millioninQ4FY12compared toanEBITofRs.6millioninQ4FY11. The company continued to consolidate its panIndia presence as it added 74 stores on a net basis in Q4FY12,takingitsnetworkto1,364operationalstoresbyMarch31,2012.DuringQ4,itadded81stores andclosed7underperformingstores. Thebatchofmaturestores(preMarch2007)continuestoperformstronglywithlikeforlikegrowthin revenues /store at 13% inQ4FY12. The segment ofmature stores reportedfurther improvements in profitabilitywithanEBITDAmarginof5.8%inQ4FY12,anincreaseof36basispointsoverQ4FY11.

SubsidariesandJVs
ApolloMunichHealthInsuranceCompanyLimited DuringFY12,thecompanyachievedaGrossWrittenPremiumofRs.4,759millionagainstaGWPofRs. 2,835millioninFY11.Similarly,theearnedpremiumdemonstratedtractionexpanding102%toRs.3,008 million in FY12 compared to Rs. 1,487 million in FY11. Driven by improved pricing and prudent underwriting,theincurredclaimratioimprovedto58%inFY12from62%inFY11. ImprovedoperatingmetricswereapparentinthereducedlossattheEBITDAlevelofRs.382millionin FY12comparedtoRs.705millioninFY11.Thecombinedratioimprovedfrom128%inFY11to109%in FY12.AsofMar31,2012thecompanyhas50officesacrossIndiaandRs.4,192millionofAUMs. ApolloHealthStreet AHS reported revenues of Rs. 4,909 million in FY12, an increase of 9.7% compared to revenues of Rs. 4,476millioninFY11.Revenuegrowthwasdrivenbyincreasedbusinessvolumesandmomentuminnew businessdrivenbyavastlystrengthenedsalesteam. EBITDAwas higher by 61.6% at Rs. 842 million in FY12 and the EBITDA margin improved by 554basis pointsto17.2%.PATwasRs1million.TherewasalsoaoneofflitigationcostofapproximatelyRs.101 millionduringtheyear. Accreditations&Awards TheFederationofIndianChambersofCommerceandIndustry(FICCI)awardedDr.PrathapReddythe LifetimeAchievementAward2011 At the Asian Hospital Management Awards, 2011 Apollo Hospitals, Chennai was the winner in the OperationalCustomerServiceProjectCategory;ApolloGleneaglesHospitals,Kolkatawasrunnerupin the Cost Reduction Project Category and Apollo Hospitals, Hyderabad was runnerup in the Clinical ServiceImprovementProjectCategory. The Apollo Clinical Excellence Forum (ACEF) was adjudged among the top 3 in the Public Choice categoryunderInnovativeInitiativesinHealthcarebythepublicintheeHealthWorldAwards2011. TheCriticalCareUnitsofApolloMainHospital,ChennaiandApolloSpecialityHospital,Maduraiwere ranked as Best of Best for applying evidence based nutrition practices for managing critically ill patients. ApolloHospitals,Chennaiwasjudgedatthe6thplaceandApolloSpecialityHospital,Maduraiatthe 7thplaceforBestCriticalCareNutrition.
ENDS
3